# Investigating the Inotropic Potential of Apelin

> **NCT01179061** · NA · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 24 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Apelin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01179061
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01179061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01179061, "Investigating the Inotropic Potential of Apelin". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01179061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*